Evidence map›Paper›PMID 33891558›Full record

ArticleScience immunology2021

Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage.

Michael H Askenase, Brittany A Goods, Hannah E Beatty, Arthur F Steinschneider, Sofia E Velazquez, Artem Osherov, Margaret J Landreneau, Shaina L Carroll, Tho B Tran, Victor S Avram and 20 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Piezoelectric g-CMaterials today. Bio · 2026
    Article
  6. Article
  7. Single-cell analysis of microglia and monocyte dynamics uncovers distinct TNF-driven neuroimmune signatures in humans after intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  8. Cytokine markers in intracerebral hemorrhage are linked to ventricular imaging and outcomes.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026
    Article
  9. Review
  10. Molecular heterogeneity in human stroke - What can we learn from the peripheral blood transcriptome?Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. FOXO1-driven metabolic reprogramming of hematomal CD8Cellular & molecular immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 8 institutions in 2 countries.

Michael H AskenaseDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5990-7289
Brittany A GoodsInstitute for Medical Engineering & Science (IMES) and Department of Chemistry, MIT, Cambridge, MA, USA.
Hannah E BeattyDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0077-0270
Arthur F SteinschneiderDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.
Sofia E VelazquezDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5954-3518
Artem OsherovDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1595-4486
Margaret J LandreneauDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-6432-4889
Shaina L CarrollInstitute for Medical Engineering & Science (IMES) and Department of Chemistry, MIT, Cambridge, MA, USA.ORCID 0000-0002-8051-5850
Tho B TranDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0973-2908
Victor S AvramDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2315-6919
Riley S DrakeInstitute for Medical Engineering & Science (IMES) and Department of Chemistry, MIT, Cambridge, MA, USA.ORCID 0000-0002-0323-6137
G James GatterInstitute for Medical Engineering & Science (IMES) and Department of Chemistry, MIT, Cambridge, MA, USA.ORCID 0000-0002-4755-5420
Jordan A MasseyDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-6195-1801
Saravanan S KaruppagounderSperling Center for Hemorrhagic Stroke Recovery, Burke Neurological Institute at Weill Cornell Medicine, White Plains, NY, USA.
Rajiv R RatanSperling Center for Hemorrhagic Stroke Recovery, Burke Neurological Institute at Weill Cornell Medicine, White Plains, NY, USA.
Charles C MatoukDepartment of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
Kevin N ShethDepartment of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2003-5473
Wendy C ZiaiDivision of Brain Injury Outcomes, Johns Hopkins University, Baltimore, MD, USA.
Adrian R Parry-JonesDivision of Cardiovascular Sciences, School of Medicine, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Issam A AwadNeurovascular Surgery Program, Section of Neurosurgery, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Mario ZuccarelloDepartment of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.ORCID 0000-0002-7892-7450
Richard E ThompsonDivision of Brain Injury Outcomes, Johns Hopkins University, Baltimore, MD, USA.
Jesse DawsonInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0001-7532-2475
Daniel F HanleyDivision of Brain Injury Outcomes, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-9536-4258
J Christopher LoveKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA. lauren.sansing@yale.edu shalek@mit.edu clove@mit.edu.ORCID 0000-0003-0921-3144
Alex K ShalekInstitute for Medical Engineering & Science (IMES) and Department of Chemistry, MIT, Cambridge, MA, USA. lauren.sansing@yale.edu shalek@mit.edu clove@mit.edu.ORCID 0000-0001-5670-8778
Lauren H SansingDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA. lauren.sansing@yale.edu shalek@mit.edu clove@mit.edu.ORCID 0000-0002-6898-1680
MISTIE III Consortium
ICHseq investigators
ICHseq Investigators MISTIE III Investigators
Yale University · USJohns Hopkins University · USBroad Institute · USCornell University · USNational Health Service · GBUniversity of Cincinnati Medical Center · USUniversity of Chicago · USUniversity of Glasgow · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN SupplementU24TR001609 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2016 to 2022
$36.3M
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating CenterU01NS080824 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2013 to 2017
$23.2M
Short-Term Reserch Training: Students in Health SchoolsT35HL007649 · NHLBI · YALE UNIVERSITY · PI Sarwat I Chaudhry, Erica L Herzog · 1987 to 2026
$5.7M
Dynamic Neuroimmune Profiling in Patients with Acute Intracerebral HemorrhageR01NS097728 · NINDS · YALE UNIVERSITY · PI SANSING, LAUREN H · 2016 to 2020
$2.8M
An integrated multiplexed genomic assay for low input clinical samples1U24AI118672 · NIAID · BROAD INSTITUTE, INC. · PI SHALEK, ALEX K · 2015 to 2019
$2.0M
Characterizing spatio-temporal changes in immune cell landscapes of multiple sclerosis patients in response to B cell depletion with OcrelizumabF32AI136459 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GOODS, BRITTANY ANNE · 2018 to 2020
$184k
NCATS NIH HHS U24 TR001609NCATS NIH HHS UL1 TR001863NHLBI NIH HHS T35 HL007649NIAID NIH HHS F32 AI136459NIAID NIH HHS U24 AI118672NINDS NIH HHS R01 NS097728NINDS NIH HHS U01 NS080824
6 · The paper itself

Abstract

Opportunities to interrogate the immune responses in the injured tissue of living patients suffering from acute sterile injuries such as stroke and heart attack are limited. We leveraged a clinical trial of minimally invasive neurosurgery for patients with intracerebral hemorrhage (ICH), a severely disabling subtype of stroke, to investigate the dynamics of inflammation at the site of brain injury over time. Longitudinal transcriptional profiling of CD14

Indexed as

AdultAgedBrainCells, CulturedCerebral HemorrhageFemaleHealthy VolunteersHematomaHumansLongitudinal StudiesMacrophagesMaleMiddle AgedNeuroinflammatory DiseasesNeutrophilsPrimary Cell Culture

Identifiers

PMID33891558
PMCPMC8252865
OpenAlexW3132574802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.